A carregar...
VRC01 in Acutely Treated HIV-infected Adults: A Randomised, Double-blind, Placebo-controlled Trial
BACKGROUND: HIV-1-specific broadly neutralizing antibodies such as VRC01 could promote HIV remission by halting viral replication and clearing infected cells. We conducted a randomised, double-blinded, placebo-controlled trial of VRC01 in adults who initiated antiretroviral therapy (ART) during acut...
Na minha lista:
| Publicado no: | Lancet HIV |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6693657/ https://ncbi.nlm.nih.gov/pubmed/31000477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(19)30053-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|